Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Abbott Laboratories
(NY:
ABT
)
113.27
+0.51 (+0.45%)
Official Closing Price
Updated: 7:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Abbott Laboratories
< Previous
1
2
...
23
24
25
26
27
28
29
30
31
...
33
34
Next >
Here's How Much $1000 Invested In Abbott Laboratories 10 Years Ago Would Be Worth Today
March 14, 2022
Abbott Laboratories (NYSE:ABT) has outperformed the market over the past 10 years by 3.32% on an annualized basis. Buying $1,000 In ABT: 10 years ago, an investor could have...
Via
Benzinga
10 More Major US Corporations Still Doing Business In Russia
March 11, 2022
The flow of U.S. companies exiting Russia has intensified as President Vladimir Putin’s military continues to lay waste to Ukraine. But while more than 300 major companies...
Via
Benzinga
Dividend Income Update February 2022
March 10, 2022
It’s dividend income update time. One of my favorite times of the month as I get to review my previous month of passive income received from my dividend income portfolios.
Via
Talk Markets
7 Long-Term Stocks to Buy Now and Hold Forever
March 03, 2022
Here are seven long-term stocks that fit well in most investors' portfolios as core holdings over decades, at least historically speaking. 7 Long-Term Stocks to Buy Now and Hold Forever
Via
InvestorPlace
36 Stocks To Watch After Biden's First State of The Union Address
March 02, 2022
President Joe Biden hosted his first State of the Union Address Tuesday in front of members of Congress. In the speech, Biden discussed several items that he has already helped...
Via
Benzinga
Abbott's CardioMEMS HF System Scores FDA Nod For Earlier-Stage Heart Failure
February 22, 2022
The FDA has approved an expanded indication for Abbott Laboratories' (NYSE: ABT) CardioMEMS HF System. The CardioMEMS HF System was initially...
Via
Benzinga
4 Stocks With A Perfect Dividend Triangle
February 16, 2022
Today, we present 4 stocks with a perfect dividend triangle to illustrate how it leads to robust companies.
Via
Talk Markets
Half The American Population May Suffer From Chronic Illnesses By 2025, According To This Report
February 03, 2022
Photo by Towfiqu barbhuiya on Unsplash This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. If you think the...
Via
Benzinga
Dividend Kings In Focus: AbbVie
January 31, 2022
A look at AbbVie’s business model, growth potential, and why we rate the stock as a buy for dividend growth investors.
Via
Talk Markets
Abbott Labs Outlook Cools the Omicron Led Testing Boom
January 28, 2022
Photo by Adam Nieścioruk on Unsplash
Via
Benzinga
Stock Market Whipsaws Lower On Hawkish Fed, Tesla; Apple, Microsoft Earnings Strong: Weekly Review
January 28, 2022
Microsoft and Apple earnings were strong, but the correction is getting worse.
Via
Investor's Business Daily
Abbott Labs Crushes Quarterly Views On Strong Covid Tests, But Shares Fall On Weak Outlook
January 26, 2022
Abbott reported $2.3 billion in Covid testing sales for the fourth quarter.
Via
Investor's Business Daily
10 Health Care Stocks With Whale Alerts In Today's Session
January 27, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
What 5 Analyst Ratings Have To Say About Abbott Laboratories
January 27, 2022
Over the past 3 months, 5 analysts have published their opinion on Abbott Laboratories (NYSE:ABT) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...
Via
Benzinga
Abbott Laboratories Whale Trades For January 26
January 26, 2022
Someone with a lot of money to spend has taken a bullish stance on Abbott Laboratories (NYSE:ABT). And retail traders should know. We noticed this today when the big position...
Via
Benzinga
Abbott Posts $2.3B In COVID-19 Test Sales In Q4; Issues FY22 Outlook
January 26, 2022
Abbott Laboratories (NYSE: ABT) has reported Q4 FY21 adjusted EPS of $1.32, down from $1.45 a year ago but better than the consensus of $1.21. Q4 sales of $11.5...
Via
Benzinga
The Daily Biotech Pulse: Gilead's Blood Cancer Studies Placed On Partial Clinical Hold, Immunocore Gets FDA Nod, NRx Touts Positive COVID-19 Data
January 26, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours.
Via
Benzinga
Recap: Abbott Laboratories Q4 Earnings
January 26, 2022
Abbott Laboratories (NYSE:ABT) reported its Q4 earnings results on Wednesday, January 26, 2022 at 07:30 AM. Here's what investors need to know about the announcement....
Via
Benzinga
A Peek Into The Markets: US Stock Futures Gain; Fed Policy Decision In Focus
January 26, 2022
Pre-open movers U.S. stock futures traded higher in early pre-market trade ahead of policy decision from the Federal Reserve. The Nasdaq index dropped by more than 300 points on...
Via
Benzinga
7 Stocks To Watch For January 26, 2022
January 26, 2022
Some of the stocks that may grab investor focus today are: Wall Street expects AT&T Inc. (NYSE: T) to report quarterly earnings at $0.76 per share on revenue of $40.43...
Via
Benzinga
A Preview Of Abbott Laboratories's Earnings
January 25, 2022
Abbott Laboratories (NYSE:ABT) is set to give its latest quarterly earnings report on Wednesday, 2022-01-26. Here's what investors need to know before the announcement. Analysts...
Via
Benzinga
The Week Ahead In Biotech (Jan. 23-29): Roche, Azurity FDA Decisions, J&J, Vertex Earnings, & More
January 23, 2022
Biotech stocks pulled back yet again during the week ending Jan. 21, with the sector retreating along with the broader market. The news flow tapered off following the frenetic pace of the week that...
Via
Talk Markets
Earnings Scheduled For January 26, 2022
January 26, 2022
Companies Reporting Before The Bell • Blue Foundry (NASDAQ:BLFY) is projected to report earnings for its fourth quarter. • First BanCorp (NYSE:FBP) is likely to...
Via
Benzinga
The Week Ahead In Biotech (Jan 23-29): Roche, Azurity FDA Decisions, J&J, Vertex Earnings, Samsara Vision IPO And More
January 23, 2022
Biotech stocks pulled back yet again during the week ending Jan. 21, with the sector retreating along with the broader market. The news flow tapered off following the...
Via
Benzinga
Price Over Earnings Overview: Abbott Laboratories
January 21, 2022
Right now, Abbott Laboratories Inc. (NYSE:ABT) share price is at $126.19, after a 1.1% gain. Moreover, over the past month, the stock fell by 10.80%, but in the past...
Via
Benzinga
CNBC's Final Trades: Abbott Laboratories, Starbucks, Bank of America And This Financial Services Stock
January 21, 2022
On CNBC’s “Halftime Report...
Via
Benzinga
3 Dividend Aristocrats Yielding Over 4%
January 20, 2022
When looking for great dividend stocks, start with the Dividend Aristocrats. These companies have stood the test of time.
Via
InvestorPlace
3 Dividend Stocks to Buy and Hold Forever
January 19, 2022
Investors wanting dividends to fortify their portfolio should consider dividend stocks that deliver outsized payments to shareholders.
Via
InvestorPlace
Government Website For Free At-Home COVID Test Kit Opens Ahead Of Schedule: How To Get Yours
January 18, 2022
The U.S. government was set to officially open a website for Americans to order free COVID-19 rapid test kits on Wednesday, Jan. 19, but the site has begun taking names and...
Via
Benzinga
MLK Day Global News
January 17, 2022
In Q4 China's GDP growth rate halved to 4%.
Via
Talk Markets
< Previous
1
2
...
23
24
25
26
27
28
29
30
31
...
33
34
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.